| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Kidney International “journal of the COVID-19 year” in kidney transplantation
|
Coates, P. Toby
|
|
|
98 |
6 |
p. 1404-1406
|
article
|
| 2 |
A molecular circadian clock operates in the parathyroid gland and is disturbed in chronic kidney disease associated bone and mineral disorder
|
Egstrand, Søren
|
|
|
98 |
6 |
p. 1461-1475
|
article
|
| 3 |
Angiotensin-converting enzyme inhibitors in patients with Alport syndrome: can all patients benefit?
|
Rheault, Michelle N.
|
|
|
98 |
6 |
p. 1400-1402
|
article
|
| 4 |
An initial report from the French SOT COVID Registry suggests high mortality due to COVID-19 in recipients of kidney transplants
|
Caillard, Sophie
|
|
|
98 |
6 |
p. 1549-1558
|
article
|
| 5 |
An international cohort study of autosomal dominant tubulointerstitial kidney disease due to REN mutations identifies distinct clinical subtypes
|
Živná, Martina
|
|
|
98 |
6 |
p. 1589-1604
|
article
|
| 6 |
APOL1 variant–associated kidney disease: from trypanosomes to podocyte cytoskeleton
|
Pays, Etienne
|
|
|
98 |
6 |
p. 1373-1377
|
article
|
| 7 |
A reciprocal regulation of spermidine and autophagy in podocytes maintains the filtration barrier
|
Liang, Wei
|
|
|
98 |
6 |
p. 1434-1448
|
article
|
| 8 |
Cell invasion in glomerular basement membrane: infolding glomerulopathy
|
Manabe, Shun
|
|
|
98 |
6 |
p. 1623
|
article
|
| 9 |
Clinical and genetic spectra of kidney disease caused by REN mutations
|
Schaeffer, Céline
|
|
|
98 |
6 |
p. 1397-1400
|
article
|
| 10 |
Corrigendum to “Gordon CE, Perrone RD. Tolvaptan or transplant: why wait?” Kidney Int. 2020;98:286–289
|
|
|
|
98 |
6 |
p. 1622
|
article
|
| 11 |
COVID-19 in dialysis patients: outlasting and outsmarting a pandemic
|
Hsu, Caroline M.
|
|
|
98 |
6 |
p. 1402-1404
|
article
|
| 12 |
COVID-19 infection in kidney transplant recipients at the epicenter of pandemics
|
Azzi, Yorg
|
|
|
98 |
6 |
p. 1559-1567
|
article
|
| 13 |
Editorial Board
|
|
|
|
98 |
6 |
p. A1
|
article
|
| 14 |
Epidemiology of kidney disease: consolidating and integrating the evidence to improve kidney care from early childhood to adulthood
|
Wong, Germaine
|
|
|
98 |
6 |
p. 1378-1381
|
article
|
| 15 |
Erratum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment” Kidney Int. 2020;97:1287–1296
|
Rondeau, Eric
|
|
|
98 |
6 |
p. 1621
|
article
|
| 16 |
Ethics of kidney care in the era of COVID-19
|
Martin, Dominique E.
|
|
|
98 |
6 |
p. 1424-1433
|
article
|
| 17 |
Evaluating multiple living kidney donor candidates simultaneously is more cost-effective than sequentially
|
Habbous, Steven
|
|
|
98 |
6 |
p. 1578-1588
|
article
|
| 18 |
Executive summary for China Kidney Disease Network (CK-NET) 2016 Annual Data Report
|
Yang, Chao
|
|
|
98 |
6 |
p. 1419-1423
|
article
|
| 19 |
Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome
|
Yamamura, Tomohiko
|
|
|
98 |
6 |
p. 1605-1614
|
article
|
| 20 |
IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)
|
Thaunat, Olivier
|
|
|
98 |
6 |
p. 1568-1577
|
article
|
| 21 |
In this issue—2020 draws to a close
|
Rovin, Brad H.
|
|
|
98 |
6 |
p. 1361
|
article
|
| 22 |
Journal Club
|
|
|
|
98 |
6 |
p. 1382-1384
|
article
|
| 23 |
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation
|
Małyszko, Jolanta
|
|
|
98 |
6 |
p. 1407-1418
|
article
|
| 24 |
Kidney-derived PCSK9—a new driver of hyperlipidemia in nephrotic syndrome?
|
Artunc, Ferruh
|
|
|
98 |
6 |
p. 1393-1395
|
article
|
| 25 |
Kidney-intrinsic factors determine the severity of ischemia/reperfusion injury in a mouse model of delayed graft function
|
Qiu, Longhui
|
|
|
98 |
6 |
p. 1489-1501
|
article
|
| 26 |
Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients
|
Couchoud, Cécile
|
|
|
98 |
6 |
p. 1519-1529
|
article
|
| 27 |
More reasons to use SGLT2 inhibitors: EMPEROR-reduced and DAPA-CKD
|
Nangaku, Masaomi
|
|
|
98 |
6 |
p. 1387-1389
|
article
|
| 28 |
More than ever, efficient evaluation of potential living kidney donors is needed
|
Clark, Edward G.
|
|
|
98 |
6 |
p. 1395-1397
|
article
|
| 29 |
Outcomes of patients with end-stage kidney disease hospitalized with COVID-19
|
Ng, Jia H.
|
|
|
98 |
6 |
p. 1530-1539
|
article
|
| 30 |
Podocyte healthy self-eating boosted by a spermidine meal?
|
Lenoir, Olivia
|
|
|
98 |
6 |
p. 1390-1392
|
article
|
| 31 |
Registry reports in COVID-19 patients: juggling with big data, poor data, and no data
|
Søfteland, John Mackay
|
|
|
98 |
6 |
p. 1618
|
article
|
| 32 |
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
|
Jager, Kitty J.
|
|
|
98 |
6 |
p. 1540-1548
|
article
|
| 33 |
Results of an explorative clinical evaluation suggest immediate and persistent post-reperfusion metabolic paralysis drives kidney ischemia reperfusion injury
|
Lindeman, Jan H.
|
|
|
98 |
6 |
p. 1476-1488
|
article
|
| 34 |
SARS-CoV-2 receptor networks in diabetic and COVID-19–associated kidney disease
|
Menon, Rajasree
|
|
|
98 |
6 |
p. 1502-1518
|
article
|
| 35 |
Secretion of the epithelial sodium channel chaperone PCSK9 from the cortical collecting duct links sodium retention with hypercholesterolemia in nephrotic syndrome
|
Molina-Jijon, Eduardo
|
|
|
98 |
6 |
p. 1449-1460
|
article
|
| 36 |
Sepsis-associated acute kidney injury: is COVID-19 different?
|
Kellum, John A.
|
|
|
98 |
6 |
p. 1370-1372
|
article
|
| 37 |
Significant impact of COVID-19 on organ donation and transplantation in a low-prevalence country: Australia
|
Chadban, Steven J.
|
|
|
98 |
6 |
p. 1616-1618
|
article
|
| 38 |
Sixty (plus one) breakthrough discoveries in nephrology
|
Hirakawa, Yosuke
|
|
|
98 |
6 |
p. 1362-1366
|
article
|
| 39 |
Subscription Information
|
|
|
|
98 |
6 |
p. A5
|
article
|
| 40 |
Successful simultaneous pancreas and kidney transplant in a patient post–COVID-19 infection
|
Singh, Neeraj
|
|
|
98 |
6 |
p. 1615-1616
|
article
|
| 41 |
Surveying the human single-cell landscape
|
Li, Haikuo
|
|
|
98 |
6 |
p. 1385-1387
|
article
|
| 42 |
Table of Contents
|
|
|
|
98 |
6 |
p. A6, A7, A10, A11, A12
|
article
|
| 43 |
The authors reply
|
Wanchoo, Rimda
|
|
|
98 |
6 |
p. 1620
|
article
|
| 44 |
The authors reply
|
Hazzan, Marc
|
|
|
98 |
6 |
p. 1618-1619
|
article
|
| 45 |
The Case | A 23-year-old male with hemoptysis
|
Irish, Georgina L.
|
|
|
98 |
6 |
p. 1627-1628
|
article
|
| 46 |
The Case | Severe high-anion gap metabolic acidosis
|
Jdiaa, Sara S.
|
|
|
98 |
6 |
p. 1625-1626
|
article
|
| 47 |
The Nobel Prize in chemistry in 2020: genome editing tools and their immeasurable applications for humankind
|
Higashijima, Yoshiki
|
|
|
98 |
6 |
p. 1367-1369
|
article
|
| 48 |
Thrombotic microangiopathy: COVID-19 or hydroxychloroquine?
|
Hasbal, Nuri Baris
|
|
|
98 |
6 |
p. 1619-1620
|
article
|
| 49 |
Tracheal necrotizing granulomatosis in antineutrophil cytoplasmic antibody–associated vasculitis
|
Esposito, Pasquale
|
|
|
98 |
6 |
p. 1624
|
article
|
Journal description